Pulse Biosciences Inc
Open
SectorHealthcare
26.12 1.91
Overview
Share price change
24h
Min
25.63
Max
26.3
Income | -1.1M -19M |
|---|---|
Sales | 137K 401K |
EPS | -0.241 |
Profit margin | -4,633.666 |
Employees | 116 |
EBITDA | -1.7M -19M |
Recommendations | Buy |
|---|---|
12 Months Forecast | +20.58% upside |
Next Earnings | 11 Aug 2026 |
|---|
Market Cap | 263M 1.8B |
|---|---|
Previous open | 24.21 |
Previous close | 26.12 |
News Sentiment
By Acuity
34%
66%
91 / 342 Healthcare
Pulse Biosciences Inc Chart
Past performance is not a reliable indicator of future results.
About Pulse Biosciences Inc
Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. The company offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation technology. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. Pulse Biosciences, Inc. was incorporated in 2014 and is headquartered in Hayward, California.
